Chemistry:Trifluoromescaline

From HandWiki

Trifluoromescaline (TFM), also known as 4-(trifluoromethoxy)-3,5-dimethoxyphenethylamine, is a derivative of the phenethylamine psychedelic mescaline, which has a 4-trifluoromethoxy group replacing the 4-methoxy group of mescaline. It was found to be one of the most potent compounds in the scaline series, with a reported dose of 15 to 40 mg (and 60 mg being described as a "strong overdose"), and a slow onset of action and long duration of effects, lasting 14 to 24 hours or more.[1] The drug showed about 36-fold greater activational potency at the serotonin 5-HT2A receptor compared to mescaline in vitro.[2] In addition, it appears to be much more lipophilic than mescaline (predicted log P = 1.9 vs. 0.7, respectively).[3][4] TFM was first described in the scientific literature by Daniel Trachsel by 2012.[5][1] Many other related compounds have also been described by Trachsel and colleagues.[6][5][1] It is not a controlled substance in Canada as of 2025.[7]

See also

References

  1. 1.0 1.1 1.2 Phenethylamine Von der Struktur zur Funktion. Nachtschatten Verlag AG. 2013. pp. 704–723. ISBN 978-3-03788-700-4. 
  2. "Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines". Front Pharmacol 12. 2021. doi:10.3389/fphar.2021.794254. PMID 35222010. 
  3. "Trifluoromescaline". https://pubchem.ncbi.nlm.nih.gov/compound/155884836. 
  4. "Mescaline". https://pubchem.ncbi.nlm.nih.gov/compound/4076. 
  5. 5.0 5.1 "Fluorine in psychedelic phenethylamines". Drug Test Anal 4 (7–8): 577–590. 2012. doi:10.1002/dta.413. PMID 22374819. 
  6. "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate.". Helvetica Chimica Acta 85 (9): 3019–3026. 2002. doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4. 
  7. "Controlled Drugs and Substances Act". https://laws-lois.justice.gc.ca/eng/acts/c-38.8/FullText.html. 

Template:TAAR1 modulators